{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T22:52:46Z","timestamp":1785365566178,"version":"3.55.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T00:00:00Z","timestamp":1547164800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12890-018-0775-5","type":"journal-article","created":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T06:13:40Z","timestamp":1547187220000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Safe and effective use of nivolumab for treating lung adenocarcinoma associated with sporadic lymphangioleiomyomatosis: a rare case report"],"prefix":"10.1186","volume":"19","author":[{"given":"Johan","family":"Pluvy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solenn","family":"Brosseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Stelianides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Danel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Nguenang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Crestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Zalcman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9473-1247","authenticated-orcid":false,"given":"Val\u00e9rie","family":"Gounant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,11]]},"reference":[{"key":"775_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2147\/CLEP.S50780","volume":"7","author":"AM Taveira-DaSilva","year":"2015","unstructured":"Taveira-DaSilva AM, Moss J. Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis. Clin Epidemiol. 2015;7:249\u201357.","journal-title":"Clin Epidemiol"},{"issue":"5","key":"775_CR2","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1183\/13993003.00412-2015","volume":"46","author":"S Harari","year":"2015","unstructured":"Harari S, Torre O, Cassandro R, Moss J. The changing face of a rare disease: lymphangioleiomyomatosis. Eur Respir J. 2015;46(5):1471\u201385.","journal-title":"Eur Respir J"},{"issue":"1","key":"775_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1164\/rccm.200409-1298OC","volume":"173","author":"JH Ryu","year":"2006","unstructured":"Ryu JH, Moss J, Beck GJ, Lee J-C, Brown KK, Chapman JT, et al. The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. Am J Respir Crit Care Med. 2006;173(1):105\u201311.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"775_CR4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1378\/chest.07-0898","volume":"133","author":"FX McCormack","year":"2008","unstructured":"McCormack FX. Lymphangioleiomyomatosis: a clinical update. Chest f\u00e9vr. 2008;133(2):507\u201316.","journal-title":"Chest f\u00e9vr"},{"issue":"2","key":"775_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"775_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1056\/NEJMoa1504627","volume":"373","author":"J Brahmer","year":"2015","unstructured":"Brahmer J, Reckamp KL, Baas P, Crin\u00f2 L, Eberhardt WEE, Poddubskaya E, et al. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer. N Engl J Med. 2015;373(2):123\u201335.","journal-title":"N Engl J Med"},{"issue":"17","key":"775_CR7","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","volume":"373","author":"H Borghaei","year":"2015","unstructured":"Borghaei H, Paz-Ares L, Horn L, Spigel DR, Steins M, Ready NE, et al. Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer. N Engl J Med. 2015;373(17):1627\u201339.","journal-title":"N Engl J Med"},{"issue":"19","key":"775_CR8","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","volume":"375","author":"M Reck","year":"2016","unstructured":"Reck M, Rodr\u00edguez-Abreu D, Robinson AG, Hui R, Cs\u0151szi T, F\u00fcl\u00f6p A, et al. Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer. N Engl J Med. 2016;375(19):1823\u201333.","journal-title":"N Engl J Med"},{"issue":"5","key":"775_CR9","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.anndiagpath.2015.06.003","volume":"19","author":"K Thway","year":"2015","unstructured":"Thway K, Fisher C. PEComa: morphology and genetics of a complex tumor family. Ann Diagn Pathol. 2015;19(5):359\u201368.","journal-title":"Ann Diagn Pathol"},{"issue":"6","key":"775_CR10","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, King TE, Lynch DA, Nicholson AG, et al. An official American Thoracic Society\/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733\u201348.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"775_CR11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMra1703481","volume":"378","author":"MA Postow","year":"2018","unstructured":"Postow MA, Sidlow R, Hellmann MD. Immune-Related Adverse Events Associated with Immune Checkpoint Blockade. N Engl J Med. 2018;378(2):158\u201368.","journal-title":"N Engl J Med"},{"issue":"6","key":"775_CR12","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.2353\/ajpath.2009.090525","volume":"175","author":"J Klarquist","year":"2009","unstructured":"Klarquist J, Barfuss A, Kandala S, Reust MJ, Braun RK, Hu J, et al. Melanoma-associated antigen expression in lymphangioleiomyomatosis renders tumor cells susceptible to cytotoxic T cells. Am J Pathol. 2009;175(6):2463\u201372.","journal-title":"Am J Pathol"},{"issue":"6","key":"775_CR13","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.2353\/ajpath.2009.090900","volume":"175","author":"M Carbone","year":"2009","unstructured":"Carbone M. Feasibility of immunotherapy for lymphangioleiomyomatosis. Am J Pathol. 2009;175(6):2252\u20134.","journal-title":"Am J Pathol"},{"issue":"6","key":"775_CR14","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1165\/rcmb.2018-0123OC","volume":"59","author":"K Maisel","year":"2018","unstructured":"Maisel K, Merrilees MJ, Atochina-Vasserman EN, Lian L, Obraztsova K, Rue R, et al. Immune Checkpoint Ligand PD-L1 is Upregulated in Pulmonary Lymphangioleiomyomatosis (LAM). Am J Respir Cell Mol Biol. 2018;59(6):723\u201332.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"17","key":"775_CR15","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","volume":"364","author":"FX McCormack","year":"2011","unstructured":"McCormack FX, Inoue Y, Moss J, Singer LG, Strange C, Nakata K, et al. Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med. 2011;364(17):1595\u2013606.","journal-title":"N Engl J Med"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-018-0775-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12890-018-0775-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-018-0775-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T19:05:09Z","timestamp":1578683109000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-018-0775-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,11]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["775"],"URL":"https:\/\/doi.org\/10.1186\/s12890-018-0775-5","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,11]]},"assertion":[{"value":"6 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and accompanying images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Johan PLUVY reports personal fees from BMS, non-financial support from MSD, outside the submitted work. Solenn Brosseau reports personal fees from BMS, Roche and Chugai, outside the submitted work. Sandrine Stelianides reports no conflict of interest. Claire Danel reports no conflict of interest. Marina Nguenang reports no conflict of interest. Antoine Khalil reports no conflict of interest. Bruno Crestani reports personal fees from Aventis, grants, personal fees and non-financial support from Boehringer Ingelheim, grants from CARDIF, grants from LVL, personal fees and non-financial support from Astra Zeneca, grants and non-financial support from MedImmune, grants, personal fees and non-financial support from Roche, outside the submitted work. G\u00e9rard Zalcman reports personal fees from BMS, non-financial support and other from ROCHE, personal fees from MSD, non-financial support and other from Astra-Zeneca, other from Abbvie, personal fees and other from Pfizer, outside the submitted work. Val\u00e9rie Gounant reports personal fees from BMS, ROCHE, MSD, ASTRA ZENECA, ABBVIE, outside the submitted work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"12"}}